IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
Jacob Berger A, Gigi E, Kupershmidt L, Meir Z, Gavert N, Zwang Y, Prior A, Gilad S, Harush U, Haviv I, Stemmer SM, Blum G, Merquiol E, Mardamshina M, Kaminski Strauss S, Friedlander G, Bar J, Kamer I, Reizel Y, Geiger T, Pilpel Y, Levin Y, Tanay A, Barzel B, Reuveni H, Straussman R.
Jacob Berger A, et al. Among authors: gilad s.
Nat Cancer. 2021 Oct;2(10):1055-1070. doi: 10.1038/s43018-021-00261-1. Epub 2021 Oct 21.
Nat Cancer. 2021.
PMID: 35121883